Coexisting Coronary and Carotid Artery Disease: What We Did, What Happened

Mehmet Raşit Güney1, Erhan Güler2, Erkan Albay1

  • 1Department of Cardiovascular Surgery, Dr Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital, Istanbul, Turkey.

Insights

Surgical outcomes for combined coronary and carotid artery disease show similar early survival rates. However, prioritizing coronary artery bypass grafting (CABG) alone led to increased neurological events long-term.

Area of Science:

  • Cardiovascular Surgery
  • Neurosurgery
  • Vascular Surgery

Background:

  • Coexisting coronary and carotid artery disease presents a complex surgical challenge with no established consensus on optimal management strategies.
  • High-risk patient populations require careful evaluation of surgical methods and long-term consequences.

Purpose of the Study:

  • To retrospectively evaluate and compare the surgical results and long-term outcomes of different management strategies for patients with combined coronary and carotid artery disease.
  • To identify the most effective surgical approach based on perioperative, early, and late postoperative data.

Main Methods:

  • Retrospective analysis of 196 patients treated between 2005 and 2015 for combined coronary and carotid artery disease.
  • Comparison of three surgical groups: staged procedures (carotid endarterectomy (CEA) or coronary artery bypass grafting (CABG) priority), simultaneous CABG and CEA, and CABG only for asymptomatic carotid lesions.
  • Uni-/multivariate analyses were used to evaluate perioperative, early, and late postoperative data, including all-cause mortality, cardiovascular events, and fatal neurological events.

Main Results:

  • Perioperative and early (30-day) postoperative parameters showed no significant differences between the three surgical groups.
  • Long-term follow-up (average 94.9 months) revealed similar event-free actuarial survival rates when fatal neurological events were excluded (P=0.740).
  • However, when all events were included, actuarial survival rates differed significantly (P=0.027), with a marked increase in neurological events observed between 34 and 66 months, particularly in the CABG-only group.

Conclusions:

  • Perioperative and early survival rates are comparable across staged, simultaneous, and CABG-only surgical approaches for combined coronary and carotid artery disease.
  • The strategy of performing only coronary artery bypass grafting (CABG) for patients with significant carotid stenosis was associated with a higher incidence of neurological events in the long term.
  • Clinical decision-making should prioritize the 'most threatened organ' when selecting the surgical methodology for this high-risk patient cohort.
Abstract

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
52
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
56
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
93
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
53
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
43
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
40